The mean logMAR visual acuity scores at baseline were similar across all treatment groups in both parts A and B, but visual acuity improved more rapidly in the 3 CPN groups vs the placebo groups, but the differences did not reach statistical significance at most timepoints (Supplementary Table 4, available at http://links.lww.com/JRS/B533 ).
← all excerpts
Dose-selection study of clobetasol propionate ophthalmic suspension that evaluated inflammation and pain after cataract surgery.
1
—
—